Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03352609 · ClinicalTrials.gov registry record · NA
Accelerated rTMS for the Reduction of Nicotine Craving
A NA study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03352609: Clinical Trial NA study, sponsored by Medical University of South Carolina.
NCT03352609 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03352609, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose if this study is to determine if five treatments of repetitive transcranial magnetic stimulation (rTMS) can reduce craving for cigarettes in smokers. rTMS uses magnetic pulses to stimulate the brain and is currently approved for the treatment of major depressive disorder.
Primary Outcome
Percent of participants completing the 5 session rTMS course. Hypothesize \>75% of participants will complete the 5 treatments.
Interventions
- DEVICE Sham rTMS
- DEVICE Active rTMS with MagVenture MagPro double blind rTMS system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2018-12-12 |
| Phase | NA |
Why NCT03352609 stopped before completion
NCT03352609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham rTMS is the first listed.
NCT03352609 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03352609 about?
NCT03352609 is a clinical study titled "Accelerated rTMS for the Reduction of Nicotine Craving". The purpose if this study is to determine if five treatments of repetitive transcranial magnetic stimulation (rTMS) can reduce craving for cigarettes in smokers. rTMS uses magnetic pulses to stimulate the brain and is currently approved for the treatment of major depressive disorder.
What is the current status of trial NCT03352609?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-01-01. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT03352609?
The interventions under investigation include: Sham rTMS (DEVICE), Active rTMS with MagVenture MagPro double blind rTMS system (DEVICE).
Who is sponsoring clinical trial NCT03352609?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03352609's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI